The Phase III human clinical trials of Covaxin began mid-November,
targeted to be done in 26,000 volunteers and it is the countrys first
and only Phase III efficacy study for a COVID-19 vaccine, and the
largest phase III efficacy trial ever conducted for any vaccine in
India, a press release from the vaccine maker said on Saturday night.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/bharat-biotech-recruits-23000-volunteers-for-phase-iii-trials-of-its-coronavirus-vaccine/articleshow/80079975.cms
No comments:
Post a Comment